Norpethidine

From Wikipedia, the free encyclopedia
(Redirected from Pethidine intermediate B)

Template:Short description Template:Short description Page Template:Infobox drug/styles.css has no content.

Page Module:Infobox/styles.css has no content.

Norpethidine
Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found.
Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found.
Clinical data
ATC codePage Template:Plainlist/styles.css has no content.
  • none
Legal status
Legal statusPage Template:Plainlist/styles.css has no content.
Identifiers
  • Ethyl 4-phenylpiperidine-4-carboxylate
CAS NumberPage Template:Plainlist/styles.css has no content.
PubChem CIDPage Template:Plainlist/styles.css has no content.
PubChem SIDPage Template:Plainlist/styles.css has no content.
IUPHAR/BPSPage Template:Plainlist/styles.css has no content.
DrugBankPage Template:Plainlist/styles.css has no content.
ChemSpiderPage Template:Plainlist/styles.css has no content.
UNIIPage Template:Plainlist/styles.css has no content.
KEGGPage Template:Plainlist/styles.css has no content.
ChEBIPage Template:Plainlist/styles.css has no content.
ChEMBLPage Template:Plainlist/styles.css has no content.
NIAID ChemDBPage Template:Plainlist/styles.css has no content.
PDB ligandPage Template:Plainlist/styles.css has no content.
CompTox Dashboard (EPA)Page Template:Plainlist/styles.css has no content.
Chemical and physical data
FormulaC14H19NO2
Molar mass233.311 g·mol−1
3D model (JSmol)Page Template:Plainlist/styles.css has no content.
  • O=C(OCC)C2(c1ccccc1)CCNCC2
  • InChI=1S/C14H19NO2/c1-2-17-13(16)14(8-10-15-11-9-14)12-6-4-3-5-7-12/h3-7,15H,2,8-11H2,1H3 checkY
  • Key:QKHMFBKXTNQCTM-UHFFFAOYSA-N checkY
Data page
Template:Infobox drug/data page link
Page Template:Nobold/styles.css has no content.  (verify)

Norpethidine (normeperidine, pethidine intermediate B) is a 4-phenylpiperidine derivative that is both a precursor to, and the toxic metabolite of, pethidine (meperidine). It is scheduled by UN Single Convention on Narcotic Drugs. It is a Schedule II Narcotic controlled substance in the United States and has an ACSCN of 9233. The 2014 annual manufacturing quota was 11 grams (0.39 oz).[2]

Norpethidine is a controlled drug because of its potential uses in manufacturing both pethidine itself and a range of N-substituted derivatives, but it has little opioid activity in its own right. Instead, norpethidine acts as a stimulant and causes convulsions.[3][4]

Bioaccumulation of norpethidine is a major complication when pethidine is used in medicine as an analgesic, as when pethidine is used in high doses[5] or administered by intravenous infusion,[6] norpethidine can accumulate in the body at a faster rate than it is being excreted, particularly in elderly patients[7] or those with compromised liver or kidney function,[8] resulting in a range of toxic effects, mainly convulsions, but also myoclonus[9] and hyponatremia.[10] These complications can be serious and have sometimes resulted in death.[11]

Metabolism of pethidine to norpethidine is carried out mainly by the CYP enzymes, CYP2B6, CYP2C19 and CYP3A4, in the liver, and since the activity of these enzymes can vary between individuals and can be influenced by concurrent use of other drugs, the rate and extent of norpethidine production can be difficult to predict.[12][13]

Precursor Use

Norpethidine can be used as a precursor in synthesis of other drugs, including etoxeridine,[14] benzethidine,[15] furethidine,[16] morpheridine, anileridine, phenoperidine, piminodine, oxpheneridine, pheneridine & carperidine.

See also

References

Page Template:Reflist/styles.css has no content.

  1. ^ Page Module:Citation/CS1/styles.css has no content.Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in português do Brasil). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. ^ Page Module:Citation/CS1/styles.css has no content."Conversion Factors for Controlled Substances". Diversion Control Division. Drug Enforcement Administration (DEA), U.S. Department of Justice. Archived from the original on 2016-03-02. Retrieved 2016-02-28.
  3. ^ Page Module:Citation/CS1/styles.css has no content.Umans JG, Inturrisi CE (October 1982). "Antinociceptive activity and toxicity of meperidine and normeperidine in mice". The Journal of Pharmacology and Experimental Therapeutics. 223 (1): 203–6. doi:10.1016/S0022-3565(25)33313-6. PMID 7120119.
  4. ^ Page Module:Citation/CS1/styles.css has no content.Plummer JL, Gourlay GK, Cmielewski PL, Odontiadis J, Harvey I (January 1995). "Behavioural effects of norpethidine, a metabolite of pethidine, in rats". Toxicology. 95 (1–3): 37–44. Bibcode:1995Toxgy..95...37P. doi:10.1016/0300-483x(94)02871-q. PMID 7825188.
  5. ^ Page Module:Citation/CS1/styles.css has no content.Simopoulos TT, Smith HS, Peeters-Asdourian C, Stevens DS (January 2002). "Use of meperidine in patient-controlled analgesia and the development of a normeperidine toxic reaction". Archives of Surgery. 137 (1). Chicago, Ill.: 84–8. doi:10.1001/archsurg.137.1.84. PMID 11772223.
  6. ^ Page Module:Citation/CS1/styles.css has no content.Stone PA, Macintyre PE, Jarvis DA (November 1993). "Norpethidine toxicity and patient controlled analgesia". British Journal of Anaesthesia. 71 (5): 738–40. doi:10.1093/bja/71.5.738. PMID 8251291.
  7. ^ Holmberg L, Odar-Cederlof I, Boreus LO, Heyner L, Ehrnebo M. Comparative disposition of pethidine and norpethidine in old and young patients. European Journal of Clinical Pharmacology. 1982;22(2):175-9.
  8. ^ Page Module:Citation/CS1/styles.css has no content.Pond SM, Tong T, Benowitz NL, Jacob P, Rigod J (August 1981). "Presystemic metabolism of meperidine to normeperidine in normal and cirrhotic subjects". Clinical Pharmacology and Therapeutics. 30 (2): 183–8. doi:10.1038/clpt.1981.146. PMID 7249503. S2CID 10117158.
  9. ^ Page Module:Citation/CS1/styles.css has no content.Reutens DC, Stewart-Wynne EG (December 1989). "Norpethidine induced myoclonus in a patient with renal failure". Journal of Neurology, Neurosurgery, and Psychiatry. 52 (12): 1450–1. doi:10.1136/jnnp.52.12.1450. PMC 1031622. PMID 2614458.
  10. ^ Page Module:Citation/CS1/styles.css has no content.Appel WC (November 1987). "Possible roles of normeperidine and hyponatremia in a postoperative death". Canadian Medical Association Journal. 137 (10): 912–3. PMC 1267380. PMID 3676934.
  11. ^ Page Module:Citation/CS1/styles.css has no content.Jiraki K (March 1992). "Lethal effects of normeperidine". The American Journal of Forensic Medicine and Pathology. 13 (1): 42–3. doi:10.1097/00000433-199203000-00009. PMID 1585886. S2CID 32005631.
  12. ^ Page Module:Citation/CS1/styles.css has no content.Ramírez J, Innocenti F, Schuetz EG, Flockhart DA, Relling MV, Santucci R, Ratain MJ (September 2004). "CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes". Drug Metabolism and Disposition: The Biological Fate of Chemicals. 32 (9): 930–6. doi:10.1016/S0090-9556(24)02975-1. PMID 15319333.
  13. ^ Page Module:Citation/CS1/styles.css has no content.McHugh GJ (June 1999). "Norpethidine accumulation and generalized seizure during pethidine patient-controlled analgesia". Anaesthesia and Intensive Care. 27 (3): 289–91. PMID 10389564.
  14. ^ Page Template:Citation/styles.css has no content.US granted 2858316, Henri M, "New piperidine derivatives", published Script error: No such module "auto date formatter"., assigned to UCB SA 
  15. ^ Page Module:Citation/CS1/styles.css has no content.Frearson PM, Stern ES (1958). "622. Some new analogues of pethidine. Part III. 1-Aryloxy-alkylnorpethidines, and close analogues". Journal of the Chemical Society (Resumed): 3065–7. doi:10.1039/JR9580003065.
  16. ^ Page Module:Citation/CS1/styles.css has no content.Frearson PM, Hardy DG, Stern ES (1960). "426. Some new analogues of pethidine. Part IV. Substituents at the 1-position incorporating cyclic ether groups". Journal of the Chemical Society (Resumed): 2103–7. doi:10.1039/JR9600002103.

Template:Adrenergics Template:Dopaminergics Template:Serotonergics

Retrieved from "https://cosmopedia.co/index.php?title=Norpethidine&oldid=4700445"